Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy

Detalhes bibliográficos
Autor(a) principal: Costa,Rosane Dias
Data de Publicação: 2011
Outros Autores: Mendonça,Vanessa Amaral, Penido,Rachel Adriana, Lyon,Sandra, Costa,Ana Maria Duarte Dias, Costa,Marina Dias, Terra,Fábio de Souza, Bretas,Thales Lage, Antunes,Carlos Maurício de Figueiredo, Teixeira,Antônio Lúcio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000100019
Resumo: Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in the survival of neurons and growth and differentiation of dendrites and axons. The purpose of the present study was to evaluate plasma levels of BDNF of leprosy patients at different stages of multidrug therapy (MDT) in comparison with non-infected individuals. Plasma levels of BDNF were measured by ELISA in 30 healthy controls and 37 leprosy patients at diagnosis, during and after MDT. Plasma levels of BDNF tended to be higher in control subjects in comparison with leprosy patients, but this difference does not reach statistical significance. Interestingly, BDNF levels changed following MDT, achieving statistical difference only at the 2nd dose of MDT. These results indicate that BDNF may not be a surrogate marker of leprosy infection and/or related neuropathy. Further research is needed to investigate the meaning of BDNF level changes following leprosy treatment.
id ABNEURO-1_91863ed8d54c2e8730233ea4c0a21976
oai_identifier_str oai:scielo:S0004-282X2011000100019
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapyleprosyBDNFperipheral neuropathybiomarkerfollow-upBrain-derived neurotrophic factor (BDNF) is a neurotrophin involved in the survival of neurons and growth and differentiation of dendrites and axons. The purpose of the present study was to evaluate plasma levels of BDNF of leprosy patients at different stages of multidrug therapy (MDT) in comparison with non-infected individuals. Plasma levels of BDNF were measured by ELISA in 30 healthy controls and 37 leprosy patients at diagnosis, during and after MDT. Plasma levels of BDNF tended to be higher in control subjects in comparison with leprosy patients, but this difference does not reach statistical significance. Interestingly, BDNF levels changed following MDT, achieving statistical difference only at the 2nd dose of MDT. These results indicate that BDNF may not be a surrogate marker of leprosy infection and/or related neuropathy. Further research is needed to investigate the meaning of BDNF level changes following leprosy treatment.Academia Brasileira de Neurologia - ABNEURO2011-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000100019Arquivos de Neuro-Psiquiatria v.69 n.1 2011reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/S0004-282X2011000100019info:eu-repo/semantics/openAccessCosta,Rosane DiasMendonça,Vanessa AmaralPenido,Rachel AdrianaLyon,SandraCosta,Ana Maria Duarte DiasCosta,Marina DiasTerra,Fábio de SouzaBretas,Thales LageAntunes,Carlos Maurício de FigueiredoTeixeira,Antônio Lúcioeng2011-02-18T00:00:00Zoai:scielo:S0004-282X2011000100019Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2011-02-18T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
title Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
spellingShingle Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
Costa,Rosane Dias
leprosy
BDNF
peripheral neuropathy
biomarker
follow-up
title_short Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
title_full Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
title_fullStr Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
title_full_unstemmed Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
title_sort Study of the profile of the neurotrophin BDNF in new leprosy cases before, during and after multidrug therapy
author Costa,Rosane Dias
author_facet Costa,Rosane Dias
Mendonça,Vanessa Amaral
Penido,Rachel Adriana
Lyon,Sandra
Costa,Ana Maria Duarte Dias
Costa,Marina Dias
Terra,Fábio de Souza
Bretas,Thales Lage
Antunes,Carlos Maurício de Figueiredo
Teixeira,Antônio Lúcio
author_role author
author2 Mendonça,Vanessa Amaral
Penido,Rachel Adriana
Lyon,Sandra
Costa,Ana Maria Duarte Dias
Costa,Marina Dias
Terra,Fábio de Souza
Bretas,Thales Lage
Antunes,Carlos Maurício de Figueiredo
Teixeira,Antônio Lúcio
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Costa,Rosane Dias
Mendonça,Vanessa Amaral
Penido,Rachel Adriana
Lyon,Sandra
Costa,Ana Maria Duarte Dias
Costa,Marina Dias
Terra,Fábio de Souza
Bretas,Thales Lage
Antunes,Carlos Maurício de Figueiredo
Teixeira,Antônio Lúcio
dc.subject.por.fl_str_mv leprosy
BDNF
peripheral neuropathy
biomarker
follow-up
topic leprosy
BDNF
peripheral neuropathy
biomarker
follow-up
description Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in the survival of neurons and growth and differentiation of dendrites and axons. The purpose of the present study was to evaluate plasma levels of BDNF of leprosy patients at different stages of multidrug therapy (MDT) in comparison with non-infected individuals. Plasma levels of BDNF were measured by ELISA in 30 healthy controls and 37 leprosy patients at diagnosis, during and after MDT. Plasma levels of BDNF tended to be higher in control subjects in comparison with leprosy patients, but this difference does not reach statistical significance. Interestingly, BDNF levels changed following MDT, achieving statistical difference only at the 2nd dose of MDT. These results indicate that BDNF may not be a surrogate marker of leprosy infection and/or related neuropathy. Further research is needed to investigate the meaning of BDNF level changes following leprosy treatment.
publishDate 2011
dc.date.none.fl_str_mv 2011-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000100019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000100019
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-282X2011000100019
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.69 n.1 2011
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212770235023360